巨星醫療控股(02393.HK)年度溢利減少19.5%至2.03億元 不派息
格隆匯3月27日丨巨星醫療控股(02393.HK)公佈,截至2019年12月31日止年度,公司收益49.03億元人民幣,同比增長10.3%;毛利12.65億元,同比增長5.5%;公司擁有人應占溢利2.03億元,同比減少19.5%;每股盈利8.5分,不派息。
收益增長主要源於體外診斷業務,尤其是下級醫院及部分新的上級醫院業務增長令銷量增加。毛利亦增加5.5%,主要由醫療業務的銷量增長帶動。毛利率下降1.2個百分點至25.8%(2018年:27.0%),主要是由於產品市價因4+7帶量採購政策而下跌所致。
於本年度,本集團受惠於擴充網絡的戰略計劃,取得醫療業務分部收益約人民幣44.06億元,同比增長約14.0%。分部毛利率由去年約28.5%微跌1.6個百分點至約26.9%。於本年度,巨星妥善推行其網絡擴展計劃,成功滲透內蒙古自治區。於2019年12月31日,巨星的醫療耗材經銷網絡覆蓋中國8個省份及4個一級城市。除地域擴張外,集團亦於現有網絡中的下級醫院間爭取市場份額。於本年度,巨星打進二級醫院,進一步推動銷量增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.